Dr. Strawn’s current research involves the identification of risk factors for pediatric anxiety disorders as well as the pathophysiology and psychopharmacology of these conditions. He uses functional neuroimaging and magnetic resonance spectroscopy to study the neurophysiology of pediatric generalized anxiety disorder and of the neurophysiologic effects of co-morbid anxiety on the neurobiology of other psychiatric conditions in children and adolescents. Additionally, Dr. Strawn utilizes functional magnetic resonance imaging to identify medication-related changes in brain circuits that precede clinical improvement. This work may identify early predictors of treatment response and may guide treatment choice in pediatric patients with anxiety disorders. Finally, he actively conducts clinical trials in youth with mood and anxiety disorders. Dr. Strawn has authored nearly 120 peer-reviewed publications and is a fellow of the American Academy of Child & Adolescent Psychiatry, and a member of the Anxiety Disorders Association of America and has been elected to Alpha Omega Alpha. Additionally, he is the recipient of numerous awards for teaching and research.